New Products

Premium

Bruker Daltonics this week launched the solariX, its next-generation hybrid Qq-FTMS instrument for proteomics, petroleomics, metabolomics, and small-molecule drug and metabolite MALDI imaging.

New innovations include improved broad-band mass resolving power delivering eight times more power over earlier platforms, sensitivity greater than 10 times over earlier platforms, and dynamic range. "These dramatic improvements help address today's most challenging top-down proteomics and complex mixture applications," the company said in a statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.